• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of Public Inquiries by month (includes phone, email, and letter inquiries)

Dictionary: The Division of Drug Information within CDER is responsible for answering the public's questions about the regulatory mission of FDA. Questions arrive in the form of emails or postal mail. The public also calls the agency with many questions. This measure tracks the number of public inquiries CDER receives each month. It is CDER's goal to always respond to all public inquiries.


These measures have been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber
Oct 2010N/A7,257
Nov 2010N/A8,931
Dec 2010N/A9,198
Jan 2011N/A7,985
Feb 2011N/A7,287
Mar 2011N/A9,298
Apr 2011N/A7,554
May 2011N/A6,981
Jun 2011N/A8,332
Jul 2011N/A7,253
Aug 2011N/A8,275
Sep 2011N/A7,175

FY 2011 Total: 95,526

Number of phone inquires received in the month

Dictionary: The Division of Drug Information within CDER is responsible for answering the public's questions about the regulatory mission of FDA. Questions arrive in the form of emails or postal mail. The public also calls the agency with many questions. This measure tracks the number of public inquiries CDER receives each month. It is CDER's goal to always respond to all public inquiries.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber
Oct 2010N/A5,328
Nov 2010N/A5,784
Dec 2010N/A7,442
Jan 2011N/A6,063
Feb 2011N/A5,486
Mar 2011N/A6,823
Apr 2011N/A5,539
May 2011N/A5,415
Jun 2011N/A6,709
Jul 2011N/A5,697
Aug 2011N/A6,558
Sep 2011N/A5,476

FY 2011 Total: 72,320

Percent of phone calls with first contact resolution (i.e., phone call answered by FDA staff and response given; this statistic does not include phone calls received during non-business hours)

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetPercent
Oct 2010N/A69
Nov 2010N/A69
Dec 2010N/A62
Jan 2011N/A67
Feb 2011N/A47
Mar 2011N/A75
Apr 2011N/A79
May 2011N/A76
Jun 2011N/A73
Jul 2011N/A71
Aug 2011N/A74
Sep 2011N/A74

12-month average: 70%

Number of email inquires received in the month

Dictionary: The Division of Drug Information within CDER is responsible for answering the public's questions about the regulatory mission of FDA. Questions arrive in the form of emails or postal mail. The public also calls the agency with many questions. This measure tracks the number of public inquiries CDER receives each month. It is CDER's goal to always respond to all public inquiries.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber
Oct 2010N/A1,799
Nov 2010N/A2,909
Dec 2010N/A1,691
Jan 2011N/A1,814
Feb 2011N/A1,679
Mar 2011N/A2,300
Apr 2011N/A1,916
May 2011N/A1,441
Jun 2011N/A1,509
Jul 2011N/A1,270
Aug 2011N/A1,506
Sep 2011N/A1,598

FY 2011 Total: 21,432

Percent of emails responded to in 48 hours in the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetPercent
Oct 2010N/A100
Nov 2010N/A100
Dec 2010N/A100
Jan 2011N/A100
Feb 2011N/A100
Mar 2011N/A100
Apr 2011N/A100
May 2011N/A100
Jun 2011N/A100
Jul 2011N/A100
Aug 2011N/A100
Sep 2011N/A100

Number of letter correspondence received by CDER's Office of Communication in the month (30 day due date from time of receipt for a response by CDER's Office of Communications

Dictionary: The Division of Drug Information within CDER is responsible for answering the public's questions about the regulatory mission of FDA. Questions arrive in the form of emails or postal mail. The public also calls the agency with many questions. This measure tracks the number of public inquiries CDER receives each month. It is CDER's goal to always respond to all public inquiries.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber
Oct 2010N/A130
Nov 2010N/A238
Dec 2010N/A65
Jan 2011N/A108
Feb 2011N/A122
Mar 2011N/A175
Apr 2011N/A99
May 2011N/A125
Jun 2011N/A114
Jul 2011N/A286
Aug 2011N/A211
Sep 2011N/A101

FY 2011 Total: 1,774

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.